-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA Biologics FY2026 Revenue expected to be more than $635.000M vs $633.750M Est

Benzinga·02/25/2026 21:15:56
Listen to the news
ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $635.000M vs $633.750M Est